China's First Domestic HPV Vaccine Shows 100 Pct Efficacy in Clinical Trial
Release time：2024-05-22 02:39:19 Source：International Informer news portal
-
Contact Us
- Home
- News
- People
- In-depth
- ACWF
- 2023 Women Science and Technology Innovation Pioneer...
- People Enjoy Blooming Tulips in Jinan, East...
- Flowers Bloom Across China in Spring
China's First Domestic HPV Vaccine Shows 100 Pct Efficacy in Clinical Trial
September 1, 2022 |
| A nurse shows human papillomavirus (HPV) vaccines developed by Chinese researchers at the provincial Maternity and Child Healthcare Hospital in Wuhan, central China's Hubei Province, May 18, 2020. [Xinhua/Xiong Qi] |
BEIJING, Aug. 30 (Xinhua) — A recent study has found that China's first self-developed HPV vaccine Cecolin can offer women adults full immunity against two types of human papillomavirus (HPV).
A group of Chinese researchers analyzed data from 66-month follow-up visits as a part of the bivalent vaccine's Phase 3 clinical trial and found that its efficacy against high-grade genital lesions, typical symptoms of cervical cancer, reached 100 percent.
Furthermore, the E coli-produced HPV 16/18 recombinant vaccine realized a 97 percent efficacy against persistent HPV infections, according to the study published in the journal Lancet Infectious Diseases.
The clinical trial included 7,372 healthy women aged 18 to 45, with 3,689 in the vaccinated group and 3,683 in the control group. The cumulative incidence in the vaccinated group was noticeably lower than that in the control group, according to the study.
Cecolin is jointly developed by Xiamen University and Xiamen Innovax, making China the third country in the world to attain an independent cervical cancer vaccine supply after the United States and the United Kingdom. It earned the World Health Organization Prequalification in October 2021.
(Source: Xinhua)
32.3KPlease understand that womenofchina.cn,a non-profit, information-communication website, cannot reach every writer before using articles and images. For copyright issues, please contact us by emailing: [email protected]. The articles published and opinions expressed on this website represent the opinions of writers and are not necessarily shared by womenofchina.cn.
Comments
Magazines
Projects
Photos
Special Coverage
- Previous：Supreme Court declines to hear challenge to Maryland ban on rifles known as assault weapons
- Next：Ravens sign WR Qadir Ismail, the son of former NFL receiver Qadry Ismail
Related articles
- MPs' fury at 'virtue
- Xi Holds Talks with Belarusian President
- Xi Holds Talks with Iranian President, Eyeing New Progress in Ties
- Ministry: US practice disrupts normal business activities
- Kid Rock 'uses N
- Xi Holds Talks with Belarusian President
- Beijing slams Washington for spreading false info
- China's National Legislature Holds 2nd Plenary Meeting of Annual Session
- Why US Catholics are planning pilgrimages in communities across the nation
- European leaders hit back at Macron remark
- China vows to actively promote restoration of int'l flights
- Albanese's visit boosts China
- Xi Congratulates Thuong on Assuming Vietnam's Presidency
- Multiple safety issues haunt Boeing
- Jessica Biel CHOPS her long locks into a bob after book signing in Studio City
- Night economy flourished at food street in Shaanxi
- Xi Story: At No Time Should We Focus Only on GDP Growth
- New energy projects cater to Xizang's power needs
- My fiancé died on the morning of our wedding day
- Chinese tourists' return greeted by destinations
Random recommendation
- Copyright © 2024 Powered by China's First Domestic HPV Vaccine Shows 100 Pct Efficacy in Clinical Trial ,International Informer news portal sitemap